| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Philip H Coelho last filed a Form 4 in May 2023, as Director at CPRX. The filings on record cover 2 companies. Philip H Coelho's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Philip H Coelho's trades have earned a middling insider score of 65/100 across 5 rated trades. Over a 12-month horizon, all 5 of those trades were profitable, with an average 12-month return of +16.8%.
At the last filing, the largest reported position was 204,887 shares of CPRX. The CPRX filings lean toward selling, a net 130,000 shares.
Philip H Coelho has 29 Form 4 filings on record from January 2015 to May 2023, across 2 companies: Director at Catalyst Pharmaceuticals (CPRX), 2022–2023; Director at Ampio Pharmaceuticals (AMPE), 2015–2021.
The 48 reported transactions were 15 option or other derivative awards, 8 open-market sales, 7 stock awards and 7 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 4 purchases worth about $34K and 5 sales worth about $2.1M.
The largest open-market purchase was 30,000 shares of AMPE at an average $0.56 on September 5, 2017, about $17K.
The largest open-market sale was 100,000 shares of CPRX at an average $15.87 on November 23, 2022, about $1.6M. Twelve months later CPRX was down 17%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | Director | Sell | 100,000 | $15.87 | $1,586,749.85 | -40.1% | -10.5% | -17.4% | |
| Sep 14, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | Director | Sell | 30,000 | $15.73 | $472,000.00 | -10.7% | +14.7% | -17.5% | |
| May 21, 2021 | AMPE Ampio Pharmaceuticals, Inc. | Director | Sale+OE | 6,737 | $2.00 | $13,474.00 | -3.2% | - | - | |
| Apr 29, 2021 | AMPE Ampio Pharmaceuticals, Inc. | Director | Sale+OE | 3,263 | $2.00 | $6,526.00 | -1.6% | - | - | |
| Apr 27, 2021 | AMPE Ampio Pharmaceuticals, Inc. | Director | Sale+OE | 20,000 | $2.00 | $40,000.00 | -8.9% | - | - | |
| Sep 27, 2017 | AMPE Ampio Pharmaceuticals, Inc. | Director | Buy | 10,000 | $0.63 | $6,270.00 | +10.6% | - | - | |
| Sep 22, 2017 | AMPE Ampio Pharmaceuticals, Inc. | Director | Buy | 4,000 | $0.60 | $2,391.80 | +4.4% | - | - | |
| Sep 19, 2017 | AMPE Ampio Pharmaceuticals, Inc. | Director | Buy | 15,000 | $0.57 | $8,518.50 | +19.8% | - | - | |
| Sep 5, 2017 | AMPE Ampio Pharmaceuticals, Inc. | Director | Buy | 30,000 | $0.56 | $16,776.00 | +65.6% | - | - |